Studies of Skin Microbes in Healthy People and in People With Skin Conditions
NCT00605878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 530
Last updated 2026-04-07
Summary
This study will examine microbes (e.g., bacteria, fungi, viruses) that live on human skin and how microbes contribute to health and disease. It will analyze healthy human skin and how the these microorganisms might change in patients with atopic dermatitis (AD), a skin condition also known as eczema.
Healthy volunteers, as well as patients with moderate to severe eczema (AD), between 2 and 40 years of age may be eligible for this study.
We also wish to enroll children and adults aged 2-40 who have been diagnosed with inherited immune disorders known as HIES (hyperimmunoglobulin-E syndrome), WAS (Wiskott-Aldrich syndrome), or DOCK8 immunodeficiency because they frequently have skin problems similar to AD.
Eligible participants undergo the following tests and procedures:
* Medical family and medication history
* Skin examination
* Blood tests (research blood as well as serum IgE, and complete blood count)
* Skin samples to analyze microbes. Samples are obtained by the following methods: swabbing the skin with a cotton swab; scraping (scratching) the skin gently with a blade to remove only the outermost skin layers; and, only in adults, biopsy (surgical removal) of a small skin sample less than 1/4-inch (5 mm) in diameter.
* Nose swabs to analyze microbes.
* Patients with eczema may have photographs of their skin taken to help monitor the skin rashes.
Participants may be contacted periodically for follow-up studies. Patients with atopic dermatitis may have additional skin samples collected to examine changes in the skin bacteria over time and during all of the stages of eczema. In addition, patients who have a flare of their eczema are asked to undergo a skin sample collection as soon as possible.
Conditions
Sponsors & Collaborators
-
National Human Genome Research Institute (NHGRI)
lead NIH
Principal Investigators
-
Julie A Segre, Ph.D. · National Human Genome Research Institute (NHGRI)
Eligibility
- Min Age
- 2 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-01-22
Countries
- United States
Study Locations
More Related Trials
-
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
NCT07146971 ·Status: RECRUITING ·Phase: PHASE1
-
The Skin Microbiota in Skin Disease and Eczema
NCT06924333 ·Status: ENROLLING_BY_INVITATION
-
Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic Dermatitis
NCT04771910 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis
NCT07017348 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
NCT05579899 ·Status: COMPLETED ·Phase: PHASE2
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Targeted Microbiome Transplant in Atopic Dermatitis
NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
NCT03158012 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
NCT05870865 ·Status: COMPLETED ·Phase: PHASE2
-
MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
NCT06455891 ·Status: COMPLETED
-
Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
NCT02144142 ·Status: WITHDRAWN ·Phase: PHASE2
-
Staphylococcus Aureus in Atopic Dermatitis Immunopathology
NCT04715087 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06815380 ·Status: RECRUITING
-
Finding Patterns In Clinical Trial Experiences of Patients With Eczema
NCT05747378 ·Status: NOT_YET_RECRUITING
-
A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients
NCT04699695 ·Status: UNKNOWN
-
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
NCT06899204 ·Status: RECRUITING
-
Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
NCT00406081 ·Status: COMPLETED
-
Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis
NCT06026891 ·Status: RECRUITING ·Phase: PHASE3
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Atopic Dermatitis (AD) and Food Allergy
NCT03168113 ·Status: COMPLETED
-
Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis
NCT03018275 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
NCT00001760 ·Status: COMPLETED
-
Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
NCT01782703 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus
NCT00407069 ·Status: COMPLETED
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268 ·Status: RECRUITING ·Phase: PHASE3